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Eriosema  campestre  var.  macrophylum  (Grear)  Fortunato,  Fabaceae,  is  a native  plant  of the  Brazilian  Cer-
rado and  the  decoction  of  its  roots  has  been  used  by  folk  medicine  for the  therapy  of inﬂammatory
diseases.  In this  study  we  aimed  to investigate  the  effect  of the dichloromethane–ethanolic  extract
of  E. campestre  roots  on the proliferative  response  of lymphocytes  and  to examine  the  proﬁle  of  IL-
2  production.  The  effect  of dichloromethane–ethanolic  extract  of  E. campestre  on  the  proliferation  of
phytohemagglutinin-stimulated  lymphocytes  was  evaluated  by  using  ﬂow  cytometry  and  the  cell  super-
natants were  assayed  for IL-2  concentrations  by using  an  enzyme-linked  immunosorbent  assay.  The
phytochemical  screening  of  E. campestre  roots  was  performed  to determine  the  main  secondary  metabo-
lites  through  chromogenic  and  precipitation  reactions  and  by using  HPLC-PAD.  In  addition  to  the  presence
of  subclasses  of  ﬂavonoids  (ﬂavones  and  ﬂavonols)  in dichloromethane–ethanolic  extract  of  E. campestre,
we  observed  that  the  extract  induced  a concentration-dependent  decrease  in  IL-2  levels  on  the  super-
natant  of  the  cell  cultures  as well  as  an antiproliferative  effect  on T  lymphocytes,  including  CD4+  and  CD8+
cells.  The  anti-inﬂammatory  effects  attributed  to E. campestre  by  folk  medicine  may  partly  be  explained
by  its antiproliferative  action  on  T  lymphocytes.
ileira© 2015  Sociedade  Bras
ntroduction
Inﬂammation is a complex immune response that involves mul-
iple factors. The initial events result in the activation of innate
mmune responses and involvement of enzyme systems (Nathan,
002; Medzhitov, 2008). In late events, cooperation between T and
 lymphocytes contributes to antigen-speciﬁc antibody produc-
ion; T lymphocytes initiate a cell-mediated immune-inﬂammation
rocess in situ and maintain the activation of phagocytic cells by
ransforming them into tissue-destructive effector cells (Barton,
008). In chronic inﬂammatory diseases, the permanent activa-
ion and proliferation of T lymphocytes amplify tissue damage and
ontribute to the clinical outcome observed in these diseases, in
ddition to the cellular interactions occurring in the affected sites
Cai et al., 2012; Chimenti et al., 2013).
∗ Corresponding author.
E-mail: gustavomelo@ufvjm.edu.br (G.E.A. Brito-Melo).
http://dx.doi.org/10.1016/j.bjp.2015.08.009
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
Since chronic inﬂammatory disorders are characterized by the
high activation and proliferation of T lymphocytes, most immuno-
suppressive drugs aim to block the cell cycle progression of these
cells (Macián, 2005). In addition to the drugs registered for ﬁrst-line
therapy, which may  have many and sometimes severe side effects
(De Mattos et al., 2000), there are numerous alternative herbal
treatments with promising, but not yet proven, efﬁcacy (Reuter
et al., 2010).
Eriosema campestre var. macrophylum (Grear) Fortunato,
Fabaceae, is a plant popularly known as “pustemeira” and is native
to the Brazilian Cerrado (Grear, 1970; Fortunato, 1999). This species
consists of small and erect herbs ranging from 14 to 17.5 cm/high,
with yellow ﬂowers and fusiform roots (Rogalski and Miotto, 2011).
The decoction of E. campestre roots has been described and used by
folk medicine for the therapy of inﬂammatory diseases including
inﬂammatory skin disorders such as psoriasis. However, no study
of the chemical composition of this plant or any biological analysis
has yet provided evidence regarding the effectiveness of this plant
as an anti-inﬂammatory.
 Ltda. All rights reserved.
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We  decided to perform a phytochemical screening to charac-
erize the main classes of secondary metabolites present in the
lant extract as well as to investigate the proﬁle of its chemical
omposition. Moreover, in addition to the role of T lymphocytes in
he pathological process of chronic inﬂammatory diseases, we also
nvestigated the effect of the dichloromethane–ethanolic extract
f E. campestre roots (DEEC) on the proliferative response of lym-
hocytes as well as the proﬁle of IL-2 production, the cytokine
ssential for the expansion of these cells during the adaptive
mmune response.
aterials and methods
lant material
Fresh Eriosema campestre var. macrophylum (Grear) Fortunato,
abaceae, plants were collected in the city of Datas, Minas Gerais,
razil (S 18◦27.318′, W 43◦39.764′, 1223 m altitude). Botanical
dentiﬁcation was performed by Dr. Ana Paula Fortuna Perez,
urator of Herbario BOTU, Department of Botany, Universidade
stadual Paulista, Botucatu, SP, Brazil, and a specimen was
eposited under voucher number 881 at Jeanine Felﬁli Dendrologic
erbarium of the Federal University of Jequitinhonha and Mucuri
alleys.
reparation of plant extracts
The roots of E. campestre were dried to a constant weight at room
emperature. The dried material (450 g) was ground and macerated
n a mixture of dichloromethane and ethanol (1:1 v/v) for 72 h at
oom temperature. The macerate was separated by ﬁltration and
oncentrated under vacuum on a rotatory evaporator (Fisatom,
odel 801, Brazil) at 40 ◦C to furnish a brown residue (12.1 g). A
.0 mg/ml  solution of the residue (DEEC) in DMSO (Sigma, USA)
as prepared. Small stock aliquots were kept at −20 ◦C until the
ime of use. New dilutions of the extract in DMSO were performed
o obtain the required concentration in the cell culture medium.
hromatographic proﬁle using high performance liquid
hromatography (HPLC)
eagents
HPLC-grade methanol was obtained from J. T. Baker (Ecatepec,
exico), HPLC-grade acetonitrile was obtained from Tedia High
urity Solvents (Fairﬁeld, USA), triﬂuoroacetic acid was purchased
rom Synth (São Paulo, Brazil) and HPLC-quality ultrapure water
as prepared by using a Millipore Milli-Q Direct-8 System (Biller-
ca, USA).
hromatographic analysis
Samples of DEEC diluted to 10 mg/ml  were dissolved in HPLC-
rade methanol, ﬁltered through a 0.2 m membrane and analyzed
n a Thermo Accela HPLC system (Thermo Fisher Scientiﬁc Inc.,
altham, USA) with a solvent delivery unit, on-line degasser,
olumn oven and autosampler, and equipped with a photodiode
rray detector (PAD). For data analysis, we used ChromQuest
oftware (Version 5.0, Thermo Fisher Scientiﬁc Inc., Waltham,
SA). A Luna C18(2) analytical column (150 × 4.6 mm;  particle size
 m;  Phenomenex, USA) was used. The sample was eluted by a
radient elution employing ultrapure water (Solvent A) and ace-
onitrile (Solvent B), both containing 0.1% v/v triﬂuoroacetic acid:
–5 min, 90% of A, 50 min, 100% B; after 10 min  the column was re-
quilibrated with 90% A. The column temperature was maintained
t 40 ◦C. Analysis was performed at a ﬂow rate of 1.0 ml/min and
as monitored at 288 nm.armacognosia 26 (2016) 464–470 465
Biological samples and preparation of peripheral blood
mononuclear cells (PBMC)
Peripheral blood was  obtained from 22 healthy adult donors.
Volunteers with any infectious, autoimmune diseases or making
use of antibiotics, anti-inﬂammatory medication, corticosteroids
or other immunosuppressive drugs were not considered for blood
donation. Informed written consent was  obtained from all par-
ticipants. The study was  approved by the Ethical Committee
at the UFVJM, Diamantina, Minas Gerais, Brazil (register code
569.313/2014).
PBMC was isolated from heparinized human peripheral blood
samples (15 ml)  by using the Ficoll-Paque (speciﬁc gravity 1.077)
gradient density method, as described previously by Bicalho et al.
(1981). Peripheral blood was  diluted with phosphate-buffered
saline (PBS; pH 7.2) and centrifuged in a Ficoll-Histopaque (Sigma,
USA) discontinuous gradient at 400 × g at room temperature
for 30 min  for obtaining the characteristic layer containing the
mononuclear cells. PBMC was collected, washed with PBS and
centrifuged (240 × g at room temperature for 7 min). Cells were sus-
pended at a concentration of 1 × 107 cells/ml in PBS or RPMI-1640
medium (Sigma, USA) supplemented with 10% heat-inactivated
fetal calf serum (FCS; Gibco, Invitrogen Corporation, USA), 2 mM
l-glutamine (Sigma, USA) and an antibiotic/antimycotic cocktail
(100 UI/ml penicillin G, 100 g/ml streptomycin and 250 ng/ml
amphotericin B – Sigma, USA). The PBMC from each research sub-
ject was  obtained separately and used for cell culture analysis
individually.
Cell viability analysis
PBMC (5 × 105) were cultured with 0.5% dimethyl sulfoxide
(DMSO), as solvent control, or DEEC (100, 50, 25 or 12.5 g/ml)
at 37 ◦C in a humidiﬁed incubator with a 5% CO2-air atmosphere
for 24 h or 5 days. Untreated PBMC was  used as the unstimulated
cell culture control (Ctrl). In the end of the incubation, cells were
washed with PBS, centrifuged (240 × g, room temperature, 7 min)
and resuspended with 0.5 ml  PBS. Then, 10 l of cell suspension
was mixed with an equal volume of 0.4% trypan blue (Sigma, USA).
Total, viable and nonviable cell numbers were counted under the
microscope by using a hemocytometer Neubauer chamber.
Lymphocyte proliferative response
PBMC (1 × 107 cells) were resuspended in PBS and labeled
with 1 M of BD HorizonTM Violet Proliferation Dye 450 (VPD
450, BD Biosciences, USA) for 15 min  at 37 ◦C (Lyons, 1999). The
VPD 450-stained PBMC (5 × 105 cells/well in 24-well plate) were
cultured in RPMI-1640 containing 10% FCS (Gibco, Invitrogen Cor-
poration, USA), 2 mM l-glutamine and the antibiotic–antimycotic
cocktail (Sigma, USA), with or without phytohemagglutinin (PHA
5 g/ml). Cells were also stimulated with PHA in combination
with 0.5% DMSO (solvent control) or different concentrations
of DEEC (25, 12.5 or 6.25 g/ml). Cells stimulated with PHA in
combination with dexamethasone at 8 g/ml (Aché, Brazil) were
used as the inhibition control (DEXA). The plate was kept in
a humidiﬁed incubator with a 5% CO2 air atmosphere for ﬁve
days at 37 ◦C. After incubation, cells were harvested, washed
in PBS and stained with speciﬁc monoclonal antibodies (mAB)
for human CD4 (CD4 mAb  phycoerythrin conjugated – CD4/PE)
and CD8 (CD8 mAb  conjugated with ﬂuorescein isothiocyanate –
CD8/FITC) (both from BD Biosciences, USA). Samples were ana-
lyzed on a BD FACSCanto II with BD FACSDiva software, and 50,000
events were acquired for each tube. Proliferation was measured
based on the dilution of VPD 450 (diminished staining intensity).
The proliferative index (PI) was  then calculated from the violet
466 M.G. Santos et al. / Revista Brasileira de F
102
0
500
M1
1000
1500
0
500 B
C
D
A
400
300
200
100
0
500
350
300
250
200
150
100
50
0
400
300
200
100
103 10 4 10 5
102 10 3 10 4 10 5
102 10 3 10 4 10 5
102 10 3
VPD450 (FI)
M5
M4
M3
M2 M1
M5
M6
M4
M3
M2 M1
M5
M4
M6
Co
un
t
M3
M2
M1
104 10 5
Fig. 1. Analysis of cell proliferation using Violet Proliferation Dye (VPD) 450 in ﬂow
cytometry. A, VPD 450-stained cells derived from unstimulated cultures; B, VPD
450-stained cells in cultures stimulated with phytohemagglutinin (PHA), C, VPD
450-stained cells in cultures stimulated with PHA and treated with DMSO (solvent
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intensity analysis of bands I and II in the UV/VIS spectra suggestsontrol), D, VPD 450-stained cells in cultures stimulated with PHA and treated with
EEC 25 g/ml.
uorescence histograms (Fig. 1) by using the following formula,
s described by Angulo and Fulcher (1998): PI = (100 − Y)/Y, where
 (%) = X0 + X1/2 + X2/4 + X3/8 + X4/16 + X5/32; X0 represents the
ercentage of T-cells that did not divide (located in M1), and X1–X5
epresents the peaks of gradual division (located in M2–M6).
L-2 production
PBMC (5 × 105 cells/well on 24-well plates) were cultured
n RPMI-1640 containing 10% FCS (Gibco, Invitrogen Corpora-
ion, USA), 2 mM l-glutamine, the antibiotic–antimycotic cocktail
Sigma, USA) and PHA (5 g/ml) with (i) PBS (control), (ii) 0.5%
MSO (solvent control) or (iii) different concentrations of DEEC
25, 12.5 or 6.25 g/ml). Cells stimulated with PHA in combina-
ion with dexamethasone at 8 g/ml were used as the inhibition
ontrol (DEXA). The plate was maintained at 37 ◦C in a humidi-
ed incubator with a 5% CO2 air atmosphere for 36 h, followed by
entrifugation for 10 min, at 240 × g and at room temperature. The
ell supernatants were collected and assayed for IL-2 concentra-
ions by using an enzyme-linked immunosorbent assay (ELISA; R&D
ystems, USA) according to the manufacturer’s instructions.armacognosia 26 (2016) 464–470
In brief, plates were coated with mouse capture antibody to
human IL-2 and incubated overnight at room temperature. Wells
were washed ﬁve times with PBS containing 0.05% Tween 20 (PBST)
and incubated with 1% bovine serum albumin in PBS contain-
ing 0.05% sodium azide. Different concentrations of recombinant
human IL-2 diluted in PBS (standard curve) or cell supernatants
were added and incubated at room temperature for 2 h. After wash-
ing with PBST, goat biotinylated antibodies to human anti-IL-2 were
added, and the plate was incubated at room temperature for 2 h
prior to adding streptavidin horseradish peroxidase. After detection
with tetramethylbenzidine (Sigma, USA), sulfuric acid was added
to block the enzymatic reaction. The absorbance at 450 nm was
determined in a microtiter plate reader (SpectraMax 190, Molecu-
lar Devices, USA). Concentrations of IL-2 in samples were estimated
by comparison with a standard curve.
Statistical analysis
GraphPad Prism, version 5.0 for Windows (GraphPad Software,
USA) was used for the statistical analysis, and p-values 0.05 were
considered to be statistically signiﬁcant. Data are reported as the
mean ± standard deviation (SD). The Shapiro–Wilk test was  used
to evaluate the normality of the data. Analysis of variance (one-
way ANOVA) was  employed, followed by Tukey post hoc pairwise
comparisons.
Results and discussion
E. campestre is a plant native to Brazil and its traditional use as
a therapy against chronic inﬂammatory disorders is widespread in
the Brazilian Cerrado. However, there are no reports of any chem-
ical or biological-toxicological studies for this plant thus far. Thus,
the current study provided the ﬁrst investigative contribution to
the chemical characterization and biological analysis of this plant
species.
The phytochemical analysis (Farnsworth, 1966; Bustamante
et al., 2010) of DEEC showed the presence of ﬂavonoids and ter-
penes.
A complex chemical proﬁle for DEEC was  observed in the
HPLC-PAD analysis, indicating the presence of substances of high,
medium and low polarity (Fig. 2A). High polarity compounds are
represented by peaks with shorter retention times, eluted between
1 and 20 min, because these substances have a higher afﬁnity for the
mobile phase. Some peaks were eluted between 20 and 35 min, a
fact that demonstrates the presence of medium polarity molecules.
The late eluting peaks observed between 35 and 47 min, which rep-
resent a higher afﬁnity for the non-polar stationary phase (C18),
are distinguished by a higher intensity and they seem to constitute
majority compounds compared with the other peaks. This obser-
vation indicates that the substances of low polarity predominate in
the extract.
Flavonoids have two absorption bands in the ultraviolet–visible
region: band II with a maximum absorption between 240 nm and
285 nm,  corresponding to the benzoyl group, and band I with a max-
imum absorption region from 300 to 550 nm,  which corresponds to
the cinnamoyl group. The analysis of bands I and II (absorption max-
imum and intensity) can assist in identifying the type of ﬂavonoid
(Marston and Hostettmann, 2006). The HPLC-PAD spectra showed
an absorption proﬁle in speciﬁc regions similar to those observed
for ﬂavonoids. This result agrees with the data observed in the chro-
mogenic and precipitation reactions. Moreover, the absorption andthe presence of ten ﬂavones (Fig. 2B) and four ﬂavonols (Fig. 2C) in
DEEC. This result is in agreement with the phytochemical screening
performed by chromogenic and precipitation reactions.
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avonols (C).
Several studies with other species of the Eriosema genus have
eported that ﬂavonoids are responsible for the biological activity
ttributed to these plants. In some studies, authors have reported
he presence of several novel ﬂavonoids such as Kraussianones 1–7,
bserved in the roots of E. kraussianum (Drewes et al., 2002, 2004),
rioschalcones A and B, isolated from E. glomerata (Awouafack et al.,
008), Robusﬂavones A and B, extracted from the aerial parts of E.
obustum (Awouafack et al., 2013) and Khonklonginols A–H, iso-
ated from the roots of E. chinense (Sutthivaiyakit et al., 2009). It
s possible that E. campestre contains novel molecules. This idea
upports the necessity for further chemical studies of its bioactive
ompounds.
The substances present in plant extracts might include those
ith cytotoxic activities (Veiga-Júnior et al., 2005), and the tox-
city of these compounds may  deﬁne the use of the plant as a
hytomedicine. To investigate this issue, the ﬁrst trials in our
tudy aimed to evaluate the toxicity of DEEC in human PBMC
y using the trypan blue exclusion test. After 24 h of culture
n the presence of different concentrations of the extract, we
bserved that DEEC at 12.5, 25 and 50 g/ml did not decrease
ell viability (12.5 g/ml = 97.56 ± 0.32%; 25 g/ml = 95.09 ± 1.71%;
0 g/ml = 93.88 ± 1.46%) compared with the control cultures
96.75 ± 1.49%) and solvent control (DMSO = 95.66 ± 1.56%). Data
howed cytotoxicity only when PBMC was treated with DEEC at
00 g/ml (56.60 ± 7.24%) (Fig. 3A).
After ﬁve days of cell culture, DEEC in concentrations
ower than 25 g/ml showed no cytotoxic effect on PBMC
12.5 g/ml = 93.56 ± 3.03%; 25 g/ml = 83.75 ± 6.67%) compared
ith the untreated (Ctrl = 91.50 ± 2.86%) and solvent control cul-
ures (DMSO = 85.47 ± 7.75%). However, a signiﬁcant reduction in
ell viability was observed in cultures treated with DEEC at 50 (A) and UV/VIS spectra (190–600 nm), indicating the presence of ﬂavones (B) and
(65.47 ± 10.37%) and 100 g/ml (54.70 ± 2.90%) compared with the
DMSO-treated and untreated cell cultures (Fig. 3B).
These results allowed us to choose concentrations of DEEC lower
than 25 g/ml as the optimum concentrations for use in cell pro-
liferation assays since the cells are kept in contact with an extract
for ﬁve days.
In order to understand the molecular basis for its traditional use
in the treatment of chronic inﬂammatory diseases and considering
the pivotal role of T-cells on the maintenance of the inﬂamma-
tory process, we decided to characterize the inﬂuence of DEEC on
the cell division of activated human lymphocytes by using VPD
450-labeled cells. VPD 450 is inherited by daughter cells after
cell division, and the intensity of the ﬂuorescence of each divid-
ing cell decreases proportionally along the mitosis. The dye does
not inﬂuence the viability of the stained cells. VPD 450 ﬂuores-
cence in lymphocytes was analyzed by using ﬂow cytometry in the
presence of a control medium or various concentrations of DEEC
(6.25, 12.5 and 25 g/ml) (Fig. 4A and B). The PI of total lympho-
cytes (12.5 g/ml = 1.21 ± 0.37; 25 g/ml = 0.46 ± 0.25) and T-CD8
lymphocytes (12.5 g/ml = 1.56 ± 0.39; 25 g/ml = 0.45 ± 0.15) in
cell cultures treated with DEEC at 12.5 and 25 g/ml was lower
than those observed in cell cultures treated only with PHA (total
lymphocytes = 2.12 ± 0.65, T-CD8 lymphocytes = 2.99 ± 1.53). The
proliferative response of T-CD4 lymphocytes decreased in cultures
treated with DEEC at 25 g/ml (0.47 ± 0.29) in comparison to cell
cultures treated only with PHA (2.07 ± 0.77). This antiproliferative
effect observed was due to the chemical constituents presented
in the extract, since DMSO did not alter lymphocyte cell prolifer-
ation, as shown in the solvent cell cultures of total lymphocytes
(2.11 ± 0.77) as well as the CD8 (2.56 ± 1.47) and CD4 (2.26 ± 1.09)
T lymphocyte subsets.
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Fig. 5. Analysis of IL-2 production in the supernatant human PBMC cultures acti-
vated by PHA and treated with DEEC. Human PBMC (5 × 105 cells) were cultured in
the  presence of medium, DMSO (0.5%), dexamethasone (DEXA, 8 g/ml) or different
concentrations of DEEC (6.25, 12.5 and 25 g/ml) and activated with PHA (5 g/ml)
for  36 h. The amount of IL-2 was measured in the supernatant of the cell cultures by
using an ELISA-based cytokine detection method. The results are presented as the
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67.94%, an antiproliferative effect higher than those presented by
examethasone. T-CD8 lymphocytes play an important role in viral
nfections, cancer and transplant rejection as well as in skin lesion
nd tissue damage maintenance in autoimmune and degenera-
ive inﬂammatory diseases characterized by a heightened cellular
daptive immune response (Gao et al., 2009). The inhibitory effect
f DEEC could thus be a promising therapeutic strategy in these
nﬂammatory situations, opening new perspectives for research.
T lymphocyte proliferation is initiated by bonding the T-cell
eceptor to external stimuli that initiate the secretion of the
utocrine growth factor IL-2, which, in turn, promotes the inter-
ction with the CD25 receptor that is upregulated on the surface
f activated T-cells (Ganguly et al., 2001; Malek, 2008). The effect
f DEEC on IL-2 production in the supernatant of PBMC cultures
as analyzed by using ELISA (Fig. 5). DEEC inhibited the production
f IL-2 in the PHA-stimulated cultures treated with the extract at
2.5 g/ml (28.01 ± 7.95 pg/ml) and 25 g/ml (17.02 ± 4.04 pg/ml)
ompared with the cell cultures stimulated only with PHA cultures
58.77 ± 15.70 pg/ml). Once again, DMSO was not able to inhibit the
roduction of IL-2 (DMSO = 39.79 ± 15.7 pg/ml).
These results indicated that the antiproliferative action exhib-
ted by the extract on T lymphocytes was due to its inhibitory
ction on the production of IL-2. The inhibitory effect of DEEC
25 g/ml) on the secretion of IL-2 presented an efﬁcacy of
8.33% in comparison to those observed in cultures treated with
examethasone. The expression of IL-2 involves the activation
f transcription factors, mainly NF-kB. The recognition of an
ntigen by the T lymphocyte receptor/CD3 complex, as well as
o-stimulatory stimuli initiates the activation of the signaling path-
ay related to NF-kB. This transcription factor is essential for T-cell
roliferation, cytokine production and the development of a well-
stablished cell-mediated immune response, cytokine production
nd consequently an increase of inﬂammatory mediators such as
rostaglandins and leukotriene (Kane et al., 2002; Li and Verma,
002).
The inhibition of IL-2 production is the target for several
mmunosuppressive drugs (Schreiber and Crabtree, 1992).
ecause of the inhibitory action of DEEC on cell proliferation and
ts inhibitory effect on the secretion of IL-2, in addition to thearmacognosia 26 (2016) 464–470 469
predominant presence of ﬂavonoids in the E. campestre extract,
molecules belonging to this chemical group might be the active
compounds responsible for the effects presented here. Several
studies have identiﬁed ﬂavonoids as the agents responsible for
the inhibition of lymphocyte proliferation, and this effect has
been shown to be associated with lower levels of IL-2 in cell
cultures (Gao et al., 2009; Chang et al., 2008; Gharagozloo et al.,
2010). Further studies using fractionated DEEC will be performed
to elucidate the structure of the substances responsible for the
effect demonstrated here as well as the performance of the active
fractions in inﬂammatory models in vivo.
The results suggest that the anti-inﬂammatory activity
attributed to E. campestre by folk medicine may  be, at least in part,
the result of the action of its ﬂavonoids on the activation and pro-
liferation of T lymphocytes. This ﬁnding means that E. campestre
is a promising natural source for the development of new effec-
tive phytomedicines for the treatment of the damage observed in
autoimmune and inﬂammatory degenerative diseases, especially
those mediated by T lymphocytes.
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